• aXichem posted first-half net sales of SEK 7.86 million, down 21.7% from a year earlier.
• Operating loss narrowed to SEK 7.11 million; net loss improved to SEK 7.17 million, with EPS of SEK -0.11.
• Second-quarter net sales fell 39.4% to SEK 4.03 million, while operating loss widened to SEK 4.29 million.
• Cash and cash equivalents totaled SEK 2.87 million at June 30; equity ratio rose 3 percentage points to 93%.
• EFSA published a positive opinion on EU approval for phenylcapsaicin in chicken feed; management expects a Commission decision by end-2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. aXichem AB published the original content used to generate this news brief via Cision (Ref. ID: 202608270230BITN____UKPR__SV_20260826-BIT-2370-0) on August 27, 2026, and is solely responsible for the information contained therein.